According to Neurogene's latest financial reports the company has A$0.22 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | A$0.28 B | 140.09% |
2022-12-31 | A$0.12 B | 23.87% |
2021-12-31 | A$97.3 M |